Margery Smelkinson

Title: Margery Smelkinson: Innovator in Influenza Treatment

Introduction

Margery Smelkinson is a notable inventor based in San Diego, California. She has made significant contributions to the field of medical science, particularly in the treatment and prevention of influenza infections. Her innovative approach focuses on modulating essential host signaling pathways to combat viral infections.

Latest Patents

Margery Smelkinson holds a patent for a method and composition aimed at protection and treatment against influenza viral infection. This patent, which is her sole patent, describes a method that involves modulating the activity of essential host signaling pathways, including the Hedgehog (Hh), Bone Morphogenetic Protein (BMP), and Notch (N) pathways. The invention utilizes compounds that can alter these pathways to prevent or control symptoms associated with influenza infections. This method can be used alone or in combination with other therapeutic agents for effective treatment.

Career Highlights

Throughout her career, Margery has worked with prestigious institutions such as the University of California and the Scripps Research Institute. Her work has been instrumental in advancing the understanding of viral infections and developing innovative treatment methods.

Collaborations

Margery has collaborated with notable colleagues, including Meghana Malur and Michael Oldstone. These collaborations have contributed to her research and the development of her patented methods.

Conclusion

Margery Smelkinson's innovative work in the field of influenza treatment showcases her dedication to advancing medical science. Her patent reflects a significant step forward in the fight against viral infections, highlighting her role as a leading inventor in this critical area.